The intragastric balloons market size has grown rapidly in recent years. It will grow from $22.05 billion in 2025 to $24.55 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of obesity worldwide, increasing awareness of weight management solutions, growing limitations of lifestyle-based weight loss methods, expansion of bariatric and endoscopic services, rising preference for minimally invasive treatments.
The intragastric balloons market size is expected to see rapid growth in the next few years. It will grow to $36.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for non-surgical obesity treatments, growing incidence of obesity-related comorbidities, rising focus on preventive weight management, expanding availability of endoscopic bariatric procedures, increasing patient preference for reversible weight loss options. Major trends in the forecast period include growing adoption of non-surgical weight loss procedures, rising preference for temporary and reversible bariatric treatments, increasing use of intragastric balloons for pre-operative weight reduction, expansion of intragastric balloon therapy in obesity management programs, growing acceptance of endoscopic weight loss interventions.
The rising rates of obesity are expected to significantly drive the growth of the intragastric balloon market. Obesity, defined by a body mass index (BMI) of 30 or higher, is increasingly prevalent due to factors such as poor dietary habits, sedentary lifestyles, economic conditions, marketing and advertising, genetics, psychological factors, and urbanization. Intragastric balloons offer a non-surgical solution for weight loss by occupying space in the stomach, promoting a feeling of fullness, and reducing food intake, making them an appealing option for those struggling with obesity. According to the World Obesity Atlas 2022, published by the World Obesity Federation, the global economic burden of obesity is projected to reach $4.32 trillion annually by 2035 if current trends continue. By that time, over half of the world's population (51%) could be overweight or obese, with nearly 2 billion individuals, or 1 in 4 people, expected to suffer from obesity. This growing global health challenge is a key driver for the demand for intragastric balloon treatments, further fueling market growth.
Major companies in the intragastric balloon market are developing advanced solutions, including weight loss medications, to address challenges such as dieting difficulties, costs, and fear of surgery. Weight loss medications support body weight reduction by suppressing appetite, enhancing metabolism, or limiting fat absorption. For example, in August 2025, Boston Scientific launched Endura Weight Loss Solutions, providing minimally invasive, endoscopic alternatives to surgery or long-term medication. These solutions include endoscopic sleeve gastroplasty (ESG), which reduces stomach volume by 70-80% through internal stitching, and the Orbera Intragastric Balloon System, which promotes satiety by placing a balloon in the stomach. These outpatient procedures help patients eat less, feel full sooner, and recover quickly, offering a safe and effective option for moderate obesity or patients ineligible for surgery, combined with lifestyle modifications for comprehensive obesity management.
In April 2024, Opus Diagnostics, a Sweden-based technology company, formed a partnership with Gastric Balloon Group. The partnership aims to deliver a non-invasive weight loss solution to the Ascot and Berkshire communities. Gastric Balloon Group is a UK-based company specializing in intragastric balloons for weight loss procedures.
Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies.
North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intragastric balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the intragastric balloons market by increasing duties on medical-grade silicone, polymer materials, and endoscopic device components. These impacts have raised manufacturing and procurement costs, particularly affecting silicone-based single and dual balloon systems, with north america and europe experiencing higher exposure due to reliance on imported medical materials. Hospitals and clinics have faced higher procedure costs, influencing patient affordability and adoption rates. On the positive side, tariffs have encouraged local manufacturing, alternative material sourcing, and regional production expansion, supporting long-term supply chain resilience.
The intragastric balloons market research report is one of a series of new reports that provides intragastric balloons market statistics, including intragastric balloons industry global market size, regional shares, competitors with a intragastric balloons market share, detailed intragastric balloons market segments, market trends and opportunities, and any further data you may need to thrive in the intragastric balloons industry. This intragastric balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intragastric balloons represent a minimally invasive approach to treating obesity, involving the insertion of a medical implant into the stomach to temporarily reduce its capacity. This method caters to individuals struggling with obesity, offering a non-surgical alternative that bypasses the need for general anesthesia. By occupying space in the stomach, the balloons induce a sensation of fullness, thereby curbing food intake. Typically inserted via an endoscope - a lengthy, flexible tube equipped with a camera - the procedure is performed through the mouth and into the stomach.
The primary variations of intragastric balloons include single, dual, and triple intragastric balloons, each serving as a tool for weight loss among obese patients. These balloons utilize filling materials categorized as saline-filled or gas-filled, and are distributed through various channels including online pharmacies, retail pharmacies, and hospital pharmacies. They find application across diverse areas such as obesity management, diabetes treatment, dietary control, weight reduction prior to surgery, and others. End users encompass hospitals, clinics, ambulatory surgical centers, among others.
The intragastric balloons market consists of revenues earned by entities by providing services such as patient evaluation and consultation, nutritional counseling, diagnostic tests, balloon removal, post-removal support, monitoring and follow-up care, and behavioral support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The intragastric balloon market also includes sales of biodegradable intragastric balloons, and adjustable intragastric balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intragastric balloons market size is expected to see rapid growth in the next few years. It will grow to $36.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for non-surgical obesity treatments, growing incidence of obesity-related comorbidities, rising focus on preventive weight management, expanding availability of endoscopic bariatric procedures, increasing patient preference for reversible weight loss options. Major trends in the forecast period include growing adoption of non-surgical weight loss procedures, rising preference for temporary and reversible bariatric treatments, increasing use of intragastric balloons for pre-operative weight reduction, expansion of intragastric balloon therapy in obesity management programs, growing acceptance of endoscopic weight loss interventions.
The rising rates of obesity are expected to significantly drive the growth of the intragastric balloon market. Obesity, defined by a body mass index (BMI) of 30 or higher, is increasingly prevalent due to factors such as poor dietary habits, sedentary lifestyles, economic conditions, marketing and advertising, genetics, psychological factors, and urbanization. Intragastric balloons offer a non-surgical solution for weight loss by occupying space in the stomach, promoting a feeling of fullness, and reducing food intake, making them an appealing option for those struggling with obesity. According to the World Obesity Atlas 2022, published by the World Obesity Federation, the global economic burden of obesity is projected to reach $4.32 trillion annually by 2035 if current trends continue. By that time, over half of the world's population (51%) could be overweight or obese, with nearly 2 billion individuals, or 1 in 4 people, expected to suffer from obesity. This growing global health challenge is a key driver for the demand for intragastric balloon treatments, further fueling market growth.
Major companies in the intragastric balloon market are developing advanced solutions, including weight loss medications, to address challenges such as dieting difficulties, costs, and fear of surgery. Weight loss medications support body weight reduction by suppressing appetite, enhancing metabolism, or limiting fat absorption. For example, in August 2025, Boston Scientific launched Endura Weight Loss Solutions, providing minimally invasive, endoscopic alternatives to surgery or long-term medication. These solutions include endoscopic sleeve gastroplasty (ESG), which reduces stomach volume by 70-80% through internal stitching, and the Orbera Intragastric Balloon System, which promotes satiety by placing a balloon in the stomach. These outpatient procedures help patients eat less, feel full sooner, and recover quickly, offering a safe and effective option for moderate obesity or patients ineligible for surgery, combined with lifestyle modifications for comprehensive obesity management.
In April 2024, Opus Diagnostics, a Sweden-based technology company, formed a partnership with Gastric Balloon Group. The partnership aims to deliver a non-invasive weight loss solution to the Ascot and Berkshire communities. Gastric Balloon Group is a UK-based company specializing in intragastric balloons for weight loss procedures.
Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies.
North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intragastric balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the intragastric balloons market by increasing duties on medical-grade silicone, polymer materials, and endoscopic device components. These impacts have raised manufacturing and procurement costs, particularly affecting silicone-based single and dual balloon systems, with north america and europe experiencing higher exposure due to reliance on imported medical materials. Hospitals and clinics have faced higher procedure costs, influencing patient affordability and adoption rates. On the positive side, tariffs have encouraged local manufacturing, alternative material sourcing, and regional production expansion, supporting long-term supply chain resilience.
The intragastric balloons market research report is one of a series of new reports that provides intragastric balloons market statistics, including intragastric balloons industry global market size, regional shares, competitors with a intragastric balloons market share, detailed intragastric balloons market segments, market trends and opportunities, and any further data you may need to thrive in the intragastric balloons industry. This intragastric balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Intragastric balloons represent a minimally invasive approach to treating obesity, involving the insertion of a medical implant into the stomach to temporarily reduce its capacity. This method caters to individuals struggling with obesity, offering a non-surgical alternative that bypasses the need for general anesthesia. By occupying space in the stomach, the balloons induce a sensation of fullness, thereby curbing food intake. Typically inserted via an endoscope - a lengthy, flexible tube equipped with a camera - the procedure is performed through the mouth and into the stomach.
The primary variations of intragastric balloons include single, dual, and triple intragastric balloons, each serving as a tool for weight loss among obese patients. These balloons utilize filling materials categorized as saline-filled or gas-filled, and are distributed through various channels including online pharmacies, retail pharmacies, and hospital pharmacies. They find application across diverse areas such as obesity management, diabetes treatment, dietary control, weight reduction prior to surgery, and others. End users encompass hospitals, clinics, ambulatory surgical centers, among others.
The intragastric balloons market consists of revenues earned by entities by providing services such as patient evaluation and consultation, nutritional counseling, diagnostic tests, balloon removal, post-removal support, monitoring and follow-up care, and behavioral support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The intragastric balloon market also includes sales of biodegradable intragastric balloons, and adjustable intragastric balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intragastric Balloons Market Characteristics
3. Intragastric Balloons Market Supply Chain Analysis
4. Global Intragastric Balloons Market Trends and Strategies
5. Intragastric Balloons Market Analysis of End Use Industries
7. Global Intragastric Balloons Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intragastric Balloons Total Addressable Market (TAM) Analysis for the Market
9. Intragastric Balloons Market Segmentation
10. Intragastric Balloons Market Regional and Country Analysis
11. Asia-Pacific Intragastric Balloons Market
12. China Intragastric Balloons Market
13. India Intragastric Balloons Market
14. Japan Intragastric Balloons Market
15. Australia Intragastric Balloons Market
16. Indonesia Intragastric Balloons Market
17. South Korea Intragastric Balloons Market
18. Taiwan Intragastric Balloons Market
19. South East Asia Intragastric Balloons Market
20. Western Europe Intragastric Balloons Market
21. UK Intragastric Balloons Market
22. Germany Intragastric Balloons Market
23. France Intragastric Balloons Market
24. Italy Intragastric Balloons Market
25. Spain Intragastric Balloons Market
26. Eastern Europe Intragastric Balloons Market
27. Russia Intragastric Balloons Market
28. North America Intragastric Balloons Market
29. USA Intragastric Balloons Market
30. Canada Intragastric Balloons Market
31. South America Intragastric Balloons Market
32. Brazil Intragastric Balloons Market
33. Middle East Intragastric Balloons Market
34. Africa Intragastric Balloons Market
36. Intragastric Balloons Market Competitive Landscape and Company Profiles
37. Intragastric Balloons Market Other Major and Innovative Companies
40. Intragastric Balloons Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intragastric Balloons Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intragastric balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intragastric balloons? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intragastric balloons market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Single; Dual; Triple Intragastric Balloons2) By Filling Material: Saline Filled; Gas Filled
3) By Application Areas: Obesity; Weight-loss; Pre-operative Weight Reduction; Other Applications
4) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Single Intragastric Balloon: Silicone-Based Single Balloon; Non-silicone-Based Single Balloon2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon; Non-silicone-Based Dual Balloon
3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon; Non-silicone-Based Triple Balloon
Companies Mentioned: Apollo Endosurgery Inc.; Allurion Technologies Inc.; ReShape Lifesciences Inc.; Spatz Medical; USGI Medical Inc.; Obalon Therapeutics Inc.; Bariatric Solutions International GmbH; Helioscopie SA; Silimed GmbH; Endalis; Medsil; Inamed Health; Micro-Tech (Nanjing) Co. Ltd; EndoShape Inc.; Medicone Srl; Medicrea Bariatrics; Ethicon Bariatric Technologies; Endomed Systems GmbH; BaroSense Inc.; Endolife Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intragastric Balloons market report include:- Apollo Endosurgery Inc.
- Allurion Technologies Inc.
- ReShape Lifesciences Inc.
- Spatz Medical
- USGI Medical Inc.
- Obalon Therapeutics Inc.
- Bariatric Solutions International GmbH
- Helioscopie SA
- Silimed GmbH
- Endalis
- Medsil
- Inamed Health
- Micro-Tech (Nanjing) Co. Ltd
- EndoShape Inc.
- Medicone Srl
- Medicrea Bariatrics
- Ethicon Bariatric Technologies
- Endomed Systems GmbH
- BaroSense Inc.
- Endolife Technologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 24.55 Billion |
| Forecasted Market Value ( USD | $ 36.1 Billion |
| Compound Annual Growth Rate | 10.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
